Listeria Monocytogenes to Treat Hepatic Metastases
单核细胞增生李斯特菌治疗肝转移
基本信息
- 批准号:7406622
- 负责人:
- 金额:$ 30.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAmericanAnimal ModelAttenuatedBreastCancer VaccinesCause of DeathCellsCessation of lifeCollaborationsColony-Stimulating FactorsConsultationsDendritic CellsDiagnosisDigestive System CancerDiseaseEngineeringGranulocyte-Macrophage Colony-Stimulating FactorHeart DiseasesImmuneImmune responseImmune systemImmunityImmunotherapyInfectionInflammationLaboratoriesListeriaListeria monocytogenesLiverLiver diseasesLocalizedMalignant NeoplasmsMetastatic Neoplasm to the LiverModelingMorbidity - disease rateMusOrganPatientsPopulationRadiosurgeryResearch ProposalsRespiratory SystemRoleSkin CancerT-LymphocyteTestingTimeTissuesToxic effectTumor AntigensUnited States National Institutes of HealthVaccinationVirulence Factorscancer cellcancer typechemotherapycostdaygastrointestinal systemmortalityneoplastic cellparacrineresearch studyresponsetumor
项目摘要
DESCRIPTION (provided by applicant): In 2004, about 1,368,060 Americans were expected to develop cancer and 563,700 were expected to die, more than 1,500 people a day. Cancer is the second leading cause of death in the US, exceeded only by heart disease. In the US, 1 of every 4 deaths is from cancer. The National Institutes of Health estimate overall costs for cancer in the year 2003 at $189.5 billion. [1] Many cancers such as those originating in the digestive system have a very high propensity to develop hepatic metastases and the primary cause of morbidity and mortality in many cases is from the liver metastases. Digestive system cancer deaths are expected to account for 134,840 deaths in the US in 2004. Additionally, other cancer types such as respiratory system, breast, and skin cancers also develop hepatic metastases. Despite aggressive treatments with surgery, radiation, and chemotherapy, 41% of patients diagnosed with cancer will succumb to their disease. Immunotherapy has the potential to provide an alternative systemic treatment for many cancers.
The specific aims of this research proposal are:
Specific Aim 1: Define the mechanisms by which GM-CSF secreting tumor vaccines and infection with attenuated Listeria strains eliminate metastatic disease from the liver.
Specific Aim 2: Identify an optimally attenuated strain of Listeria that has strong efficacy at targeting an immune response to the liver and that has low toxicity.
Specific Aim 3: Use attenuated Listeria strains that have been genetically engineered to express relevant tumor antigens to further enhance the targeted immune response.
Specific Aim 4: Define the role of dendritic cells in the priming and targeting of the immune response.
描述(由申请人提供):2004年,预计约有1,368,060名美国人患癌症,563,700人预计死亡,每天超过1,500人。癌症是美国第二大死因,仅次于心脏病。在美国,每4例死亡中就有1例死于癌症。美国国立卫生研究院估计,2003年治疗癌症的总费用为1895亿美元。许多癌症,如起源于消化系统的癌症,有很高的发展为肝转移的倾向,在许多病例中,发病和死亡的主要原因是肝转移。2004年美国消化系统癌症死亡人数预计将达到134840人。此外,其他类型的癌症,如呼吸系统癌、乳腺癌和皮肤癌也会发生肝转移。尽管进行了手术、放疗和化疗等积极的治疗,但41%的癌症患者最终还是会死于疾病。免疫疗法有可能为许多癌症提供另一种全身治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD D SCHULICK其他文献
RICHARD D SCHULICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD D SCHULICK', 18)}}的其他基金
University of Colorado Cancer Center Support Grant
科罗拉多大学癌症中心支持补助金
- 批准号:
10371494 - 财政年份:2021
- 资助金额:
$ 30.71万 - 项目类别:
University of Colorado Cancer Center Support Grant - CTRAC Supplement Yr 02
科罗拉多大学癌症中心支持补助金 - CTRAC 补充第 02 年
- 批准号:
10439981 - 财政年份:2021
- 资助金额:
$ 30.71万 - 项目类别:
Colorado's Partnership to Implement Evidence-Based Interventions to Reduce the Cancer Burden
科罗拉多州合作实施循证干预措施以减少癌症负担
- 批准号:
10409393 - 财政年份:2021
- 资助金额:
$ 30.71万 - 项目类别:
Interferon Signaling and the Differential Malignancy Spectrum of Down Syndrome
干扰素信号转导和唐氏综合症的鉴别恶性肿瘤谱
- 批准号:
9933418 - 财政年份:2019
- 资助金额:
$ 30.71万 - 项目类别:
Listeria Monocytogenes to Treat Hepatic Metastases
单核细胞增生李斯特菌治疗肝转移
- 批准号:
6988218 - 财政年份:2005
- 资助金额:
$ 30.71万 - 项目类别:
Listeria Monocytogenes to Treat Hepatic Metastases
单核细胞增生李斯特菌治疗肝转移
- 批准号:
7228884 - 财政年份:2005
- 资助金额:
$ 30.71万 - 项目类别:
Listeria Monocytogenes to Treat Hepatic Metastases
单核细胞增生李斯特菌治疗肝转移
- 批准号:
7085533 - 财政年份:2005
- 资助金额:
$ 30.71万 - 项目类别:
Listeria Monocytogenes to Treat Hepatic Metastases
单核细胞增生李斯特菌治疗肝转移
- 批准号:
7590470 - 财政年份:2005
- 资助金额:
$ 30.71万 - 项目类别:
GM-CSF Enhanced Colorectal Cancer Tumor Vaccine Program
GM-CSF增强型结直肠癌肿瘤疫苗计划
- 批准号:
6945464 - 财政年份:2004
- 资助金额:
$ 30.71万 - 项目类别:
GM-CSF Enhanced Colorectal Cancer Tumor Vaccine Program
GM-CSF增强型结直肠癌肿瘤疫苗计划
- 批准号:
7477966 - 财政年份:2004
- 资助金额:
$ 30.71万 - 项目类别:
相似海外基金
Collaborative Research: REU Site: Earth and Planetary Science and Astrophysics REU at the American Museum of Natural History in Collaboration with the City University of New York
合作研究:REU 地点:地球与行星科学和天体物理学 REU 与纽约市立大学合作,位于美国自然历史博物馆
- 批准号:
2348998 - 财政年份:2025
- 资助金额:
$ 30.71万 - 项目类别:
Standard Grant
Collaborative Research: REU Site: Earth and Planetary Science and Astrophysics REU at the American Museum of Natural History in Collaboration with the City University of New York
合作研究:REU 地点:地球与行星科学和天体物理学 REU 与纽约市立大学合作,位于美国自然历史博物馆
- 批准号:
2348999 - 财政年份:2025
- 资助金额:
$ 30.71万 - 项目类别:
Standard Grant
Understanding Latin American Challenges in the 21st Century (LAC-EU)
了解拉丁美洲在 21 世纪面临的挑战 (LAC-EU)
- 批准号:
EP/Y034694/1 - 财政年份:2024
- 资助金额:
$ 30.71万 - 项目类别:
Research Grant
Conference: North American High Order Methods Con (NAHOMCon)
会议:北美高阶方法大会 (NAHOMCon)
- 批准号:
2333724 - 财政年份:2024
- 资助金额:
$ 30.71万 - 项目类别:
Standard Grant
Collaborative Research: RUI: Continental-Scale Study of Jura-Cretaceous Basins and Melanges along the Backbone of the North American Cordillera-A Test of Mesozoic Subduction Models
合作研究:RUI:北美科迪勒拉山脊沿线汝拉-白垩纪盆地和混杂岩的大陆尺度研究——中生代俯冲模型的检验
- 批准号:
2346565 - 财政年份:2024
- 资助金额:
$ 30.71万 - 项目类别:
Standard Grant
REU Site: Research Experiences for American Leadership of Industry with Zero Emissions by 2050 (REALIZE-2050)
REU 网站:2050 年美国零排放工业领先地位的研究经验 (REALIZE-2050)
- 批准号:
2349580 - 财政年份:2024
- 资助金额:
$ 30.71万 - 项目类别:
Standard Grant
Collaborative Research: RUI: Continental-Scale Study of Jura-Cretaceous Basins and Melanges along the Backbone of the North American Cordillera-A Test of Mesozoic Subduction Models
合作研究:RUI:北美科迪勒拉山脊沿线汝拉-白垩纪盆地和混杂岩的大陆尺度研究——中生代俯冲模型的检验
- 批准号:
2346564 - 财政年份:2024
- 资助金额:
$ 30.71万 - 项目类别:
Standard Grant
Conference: Latin American School of Algebraic Geometry
会议:拉丁美洲代数几何学院
- 批准号:
2401164 - 财政年份:2024
- 资助金额:
$ 30.71万 - 项目类别:
Standard Grant
Collaborative Research: Ionospheric Density Response to American Solar Eclipses Using Coordinated Radio Observations with Modeling Support
合作研究:利用协调射电观测和建模支持对美国日食的电离层密度响应
- 批准号:
2412294 - 财政年份:2024
- 资助金额:
$ 30.71万 - 项目类别:
Standard Grant
Conference: Doctoral Consortium at Student Research Workshop at the Annual Conference of the North American Chapter of the Association for Computational Linguistics (NAACL)
会议:计算语言学协会 (NAACL) 北美分会年会学生研究研讨会上的博士联盟
- 批准号:
2415059 - 财政年份:2024
- 资助金额:
$ 30.71万 - 项目类别:
Standard Grant